{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:34:34Z","timestamp":1780565674556,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bcp.2017.04.020","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T04:16:43Z","timestamp":1492834603000},"page":"174-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["A systematic evaluation of microRNAs in regulating human hepatic CYP2E1"],"prefix":"10.1016","volume":"138","author":[{"given":"Yong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Tolleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgett","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weida","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaijin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baitang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2017.04.020_b0005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"58","author":"Leung","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2017.04.020_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/dmd.106.012492","article-title":"The 2006 Bernard B. Brodie Award Lecture. Cyp2e1","volume":"35","author":"Gonzalez","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2017.04.020_b0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.redox.2014.11.004","article-title":"CYP2E1 autoantibodies in liver diseases","volume":"3","author":"Sutti","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2017.04.020_b0020","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1517\/17425255.4.8.1053","article-title":"Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective","volume":"4","author":"Miller","year":"2008","journal-title":"Exp. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bcp.2017.04.020_b0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/17425250903540238","article-title":"CYP2E1 and risk of chemically mediated cancers","volume":"6","author":"Trafalis","year":"2010","journal-title":"Exp. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bcp.2017.04.020_b0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2017.04.020_b0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1152\/physrev.1997.77.2.517","article-title":"Cytochrome P-4502E1: its physiological and pathological role","volume":"77","author":"Lieber","year":"1997","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2017.04.020_b0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0076-6879(96)72020-7","article-title":"Trimethadione: metabolism and assessment of hepatic drug-oxidizing capacity","volume":"272","author":"Tanaka","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bcp.2017.04.020_b0045","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1074\/jbc.271.20.12063","article-title":"Role of CYP2E1 in the hepatotoxicity of acetaminophen","volume":"271","author":"Lee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2017.04.020_b0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.pharmtox.44.101802.121704","article-title":"Oxidative stress, toxicology, and pharmacology of CYP2E1","volume":"44","author":"Caro","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2017.04.020_b0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0026-895X(24)13476-1","article-title":"Genetic polymorphism of human CYP2E1: characterization of two variant alleles","volume":"51","author":"Hu","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2017.04.020_b0060","doi-asserted-by":"crossref","first-page":"16689","DOI":"10.1016\/S0021-9258(18)66620-7","article-title":"Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme","volume":"261","author":"Song","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2017.04.020_b0065","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1124\/dmd.115.065664","article-title":"Single-nucleotide polymorphisms in cytochrome P450 2E1 (CYP2E1) 3\u2032-untranslated region affect the regulation of CYP2E1 by miR-570","volume":"43","author":"Nakano","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2017.04.020_b0070","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bbagrm.2016.02.016","article-title":"A dual inhibition: microRNA-552 suppresses both transcription and translation of cytochrome P450 2E1","volume":"1859","author":"Miao","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2017.04.020_b0075","doi-asserted-by":"crossref","first-page":"e0132992","DOI":"10.1371\/journal.pone.0132992","article-title":"Differences in the epigenetic regulation of cytochrome P450 genes between human embryonic stem cell-derived hepatocytes and primary hepatocytes","volume":"10","author":"Park","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2017.04.020_b0080","doi-asserted-by":"crossref","first-page":"8534","DOI":"10.1038\/srep08534","article-title":"Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma","volume":"5","author":"Yu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2017.04.020_b0085","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bcp.2015.09.020","article-title":"Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells","volume":"98","author":"Yu","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.04.020_b0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12016-013-8401-z","article-title":"Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review","volume":"47","author":"Saito","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.bcp.2017.04.020_b0095","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bcp.2009.11.015","article-title":"Human CYP2E1 is regulated by miR-378","volume":"79","author":"Mohri","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.04.020_b0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bcp.2016.06.007","article-title":"MicroRNA hsa-miR-25-3p suppresses the expression and drug induction of CYP2B6 in human hepatocytes","volume":"113","author":"Jin","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.04.020_b0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bcp.2015.08.094","article-title":"MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells","volume":"98","author":"Yu","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2017.04.020_b0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/toxsci\/kfq296","article-title":"Functional genetic variants in the 3\u2032-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity","volume":"118","author":"Yu","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2017.04.020_b0115","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2217\/bmm.15.89","article-title":"MicroRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment","volume":"9","author":"Koturbash","year":"2015","journal-title":"Biomark. Med."},{"key":"10.1016\/j.bcp.2017.04.020_b0120","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCRESAHA.111.247916","article-title":"Developing microRNA therapeutics","volume":"110","author":"van Rooij","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2017.04.020_b0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cbi.2015.10.009","article-title":"Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity","volume":"255","author":"Xuan","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2017.04.020_b0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.reprotox.2013.01.003","article-title":"Alcohol modulates expression of DNA methyltranferases and methyl CpG-\/CpG domain-binding proteins in murine embryonic fibroblasts","volume":"37","author":"Mukhopadhyay","year":"2013","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.bcp.2017.04.020_b0135","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0022-3565(25)09682-X","article-title":"Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells","volume":"273","author":"Dai","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2017.04.020_b0140","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1021\/tx500504n","article-title":"Prediction of drug-induced liver injury in HepG2 cells cultured with human liver microsomes","volume":"28","author":"Choi","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bcp.2017.04.020_b0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2015.11.020","article-title":"Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles","volume":"64","author":"Verma","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2017.04.020_b0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/10590501.2014.907460","article-title":"Toxicogenomics and cancer susceptibility: advances with next-generation sequencing","volume":"32","author":"Ning","year":"2014","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"10.1016\/j.bcp.2017.04.020_b0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/taap.1998.8501","article-title":"Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice","volume":"152","author":"Zaher","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2017.04.020_b0160","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2125.2000.00167.x","article-title":"Paracetamol, alcohol and the liver","volume":"49","author":"Prescott","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcp.2017.04.020_b0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic","volume":"526","author":"Relling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2017.04.020_b0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13148-016-0229-y","article-title":"Ultraviolet-B induces ERCC6 repression in lens epithelium cells of age-related nuclear cataract through coordinated DNA hypermethylation and histone deacetylation","volume":"8","author":"Wang","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bcp.2017.04.020_b0175","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3109\/02713683.2014.957778","article-title":"Altered DNA methylation and expression profiles of 8-oxoguanine DNA glycosylase 1 in lens tissue from age-related cataract patients","volume":"40","author":"Wang","year":"2015","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.bcp.2017.04.020_b0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/cdd.2014.112","article-title":"The complexity of miRNA-mediated repression","volume":"22","author":"Wilczynska","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2017.04.020_b0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/art.38952","article-title":"MicroRNA-602 and microRNA-608 regulate sonic hedgehog expression via target sites in the coding region in human chondrocytes","volume":"67","author":"Akhtar","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bcp.2017.04.020_b0190","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs \u2013 microRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2017.04.020_b0195","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/acer.13180","article-title":"Possible mechanisms of ethanol-mediated colorectal carcinogenesis: the role of cytochrome P4502E1, etheno-DNA adducts, and the anti-apoptotic protein Mcl-1","volume":"40","author":"Koehler","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.bcp.2017.04.020_b0200","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.freeradbiomed.2007.11.004","article-title":"CYP2E1 and oxidative liver injury by alcohol","volume":"44","author":"Lu","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2017.04.020_b0205","first-page":"21","article-title":"Hepatic and renal toxicity of paracetamol in chronic alcoholic patient","volume":"17","author":"Pezzano","year":"1988","journal-title":"Presse Med."},{"key":"10.1016\/j.bcp.2017.04.020_b0210","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.taap.2012.08.015","article-title":"Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity","volume":"264","author":"McGill","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521730237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629521730237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:43:06Z","timestamp":1750203786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629521730237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":42,"alternative-id":["S000629521730237X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.04.020","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic evaluation of microRNAs in regulating human hepatic CYP2E1","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}